Search results
Results from the WOW.Com Content Network
Vitamin D may be an exception. So far, vitamin D is one of the most intensely studied supplements for MS. For several years, there has been a growing interest in the role of low vitamin D levels and an increased risk of MS attacks or exacerbations. Current research suggests a possible relationship between the two, although more-thorough studies ...
There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, reducing new radiographic and clinical relapses, slowing the progression of the disease, and managing MS symptoms. Some people have such mild symptoms that no treatment is necessary. Multiple sclerosis research laboratory at Mayo Clinic.
Answer From Iris Marin Collazo, M.D. Research has shown that maintaining enough vitamin D in the body may lower the risk of multiple sclerosis (MS). Several studies have shown that people who get more sun exposure and vitamin D in their diets are less likely to have MS. Taking vitamin D supplements is considered an important way to modify your ...
People with multiple sclerosis may also develop: Muscle stiffness or spasms. Severe weakness or paralysis, typically in the legs. Problems with bladder, bowel or sexual function. Cognitive problems, like forgetfulness or word finding difficulties. Mood problems, such as depression, anxiety or mood swings.
Answer From Iris Marin Collazo, M.D. Currently, there isn't enough evidence to know if acetyl-L-carnitine helps improve fatigue associated with multiple sclerosis (MS). More studies are needed. Acetyl-L-carnitine is a form of L-carnitine, an amino acid found in nearly all cells of the body. L-carnitine plays a critical role in turning fat into ...
Ofatumumab (Kesimpta) was approved by the FDA in 2020. This medicine is a self-injection treatment used for relapsing-remitting and secondary-progressive forms of MS. Ofatumumab is a medicine that destroys certain immune system cells that damage the body in MS. It helps reduce both relapses and progression of disability.
Mayo Clinic has a specialized Pediatric Multiple Sclerosis Center, staffed by a team of experts devoted to treating children with MS. At Mayo Clinic, researchers are always working to develop new treatments to improve outcomes for people with MS. For example, Mayo Clinic was one of the first clinics to treat MS with interferons.
Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. In this disease, the immune system attacks the myelin sheath or the cells that produce and maintain it. The attack causes swelling, also known as inflammation, and injury to the myelin sheath.
Seizures can also occur during times when MS symptoms flare up. In some cases, seizures might be the only sign of an MS flare. But, the majority of seizures occur unrelated to MS relapses, and the occurrence of a seizure soon before diagnosis of MS may just be a chance occurrence. Most seizures can be controlled with anti-seizure medication. With.
Research. Mayo Clinic researchers are working to improve the diagnosis and treatment of multiple sclerosis. Specific efforts include finding causes of the disease and developing strategies for remyelination and axonal repair. Read more about research in the Mayo Clinic Laboratories and in the Center for Multiple Sclerosis and Autoimmune Neurology.